2.79 USD
↗ 0.09 (3.33%)PRE MARKET (AS OF 04:10 AM EDT)
TransCode Therapeutics, Inc. Common Stock
RNAZNASDAQ • USD
Market: OPEN
Shares of TransCode Therapeutics, Inc. Common Stock (RNAZ) are trading at $2.79. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (167.1%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, RNAZ appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 24, 2026.
Open?$2.77
High?$2.79
Low?$2.77
Prev. Close?$2.70
Volume?310
Avg. Volume?26.7K
VWAP?$2.79
Rel. Volume?0.01x
Bid / Ask
Bid?$2.25 × 100
Ask?$3.31 × 100
Spread?$1.06
Midpoint?$2.78
Valuation & Ratios
Market Cap?2.9M
Shares Out?16.9M
Float?866.1K
Float %?91.1%
P/E Ratio?N/A
P/B Ratio?-0.10
EPS?-$43.73
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
Themes
Employees
12
Market Cap
3.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-09
Address
6 LIBERTY SQUARE
BOSTON, MA 02109
Phone: 857-301-6857
BOSTON, MA 02109
Phone: 857-301-6857
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?85
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.94Distress
Confidence?43%Low
Short InterestLow
Short % of Float?3.26%Low
Short Interest?28.3K
Days to Cover?1.8
Free Float866.1K
Avg Daily Volume15.5K
Settlement Date2026-07-31
Financial Health
Current Ratio?1.97Adequate
Quick Ratio?1.97Adequate
Cash Ratio?1.55Strong
Debt/Equity?-0.02Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-0.10CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.1CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?167.1%STRONG▾
Peers50
S&P97
ROA?-30.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-22611971
Enterprise Value?$-4873083
Fundamentals ratios updated end of day